Simplilearn’s Learning Hub+ Gains Momentum Among Enterprises; Aims to Upskill Over 50,000 Learners in 2025

One year since its inception, Simplilearn's Learning Hub+ (SLH+) has emerged as the learning library of choice for enterprises navigating the demands of AI and digital transformation. Launched with a bold vision to redefine corporate upskilling, SLH+ has proven its impact with over 25,000 licenses adopted by enterprise customers worldwide, empowering thousands of professionals with […]

Canadian Investment Regulatory Organization Trade Resumption – PBF

Trading resumes in: Company: Planet Based Foods Global Inc. CSE Symbol: PBF All Issues: Yes Resumption (ET): 9:30AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization

Canadian Investment Regulatory Organization Trading Halt – TCF.WT

The following issues have been halted by CIRO: Company: Trillion Energy International Inc. CSE Symbol: TCF.WT All Issues: No Reason: Pending Delisting Halt Time (ET): 7:44 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair

The Boeing Company Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations – BA

NEW YORK, NY / ACCESS Newswire / July 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Boeing Company ("The Boeing Company") (NYSE:BA) concerning possible violations of federal securities laws. A Boeing 787 Dreamliner aircraft operated by Air India crashed shortly after takeoff on June 12, 2025, in

GDS Announces the Final Offering Price for its C-REIT Initial Public Offering on the Shanghai Stock Exchange

(NasdaqGM:GDS),(HKSE:9698.HK), SHANGHAI, China, July 02, 2025 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that the final offering price for its previously announced China REIT (“C-REIT”) initial public offering (“IPO”) on the Shanghai Stock

Exalate Launches Advanced Freshservice Connector, Eliminating Manual IT Handoffs for Enterprise Teams

New integration solution enables real-time synchronization between Freshservice and other key business systems, protecting SLAs and streamlining complex IT environments. ANTWERP, BELGIUM / ACCESS Newswire / July 2, 2025 / Exalate, a leading provider of secure and flexible integration, today announced the launch of Exalate for Freshservice, a real-time connector that synchronizes critical IT service

GDS Announces the Final Offering Price for its C-REIT Initial Public Offering on the Shanghai Stock Exchange

GDS Announces the Final Offering Price for its C-REIT Initial Public Offering on the Shanghai Stock Exchange GlobeNewswire July 02, 2025 SHANGHAI, China, July 02, 2025 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced

ASSOCIATION OF CORPORATE COUNSEL (ACC) LAUNCHES AI CENTER OF EXCELLENCE TO EMPOWER IN-HOUSE LEGAL PROFESSIONALS

WASHINGTON, July 02, 2025 (GLOBE NEWSWIRE) — The Association of Corporate Counsel (ACC), the world's premier organization for in-house legal professionals, is proud to announce the launch of the ACC AI Center of Excellence for In-House Counsel, a dynamic, member-driven resource designed to support in-house counsel as they navigate the evolving landscape of artificial intelligence.

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

(NASDAQ:VYNE), BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today provided a program update for VYN202 following the clinical hold issued by the U.S. Food and

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202 GlobeNewswire July 02, 2025 BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today provided a program

Scroll to Top